Previous close | 89.70 |
Open | 89.29 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 92.96 - 95.07 |
52-week range | 84.53 - 119.56 |
Volume | |
Avg. volume | 63,990 |
Market cap | N/A |
Beta (5Y monthly) | 0.39 |
PE ratio (TTM) | 0.16 |
EPS (TTM) | 5.59 |
Earnings date | 30 Jul 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
RAHWAY, N.J., July 26, 2024--Merck Receives Positive EU CHMP Opinion for KEYTRUDA Plus Padcev as First-Line Treatment for Patients With Advanced Bladder Cancer
RAHWAY, N.J., July 23, 2024--Merck Announces Fourth-Quarter 2024 Dividend
Key Insights Significantly high institutional ownership implies Merck's stock price is sensitive to their trading...